ALTEOGEN Statistics
Total Valuation
ALTEOGEN has a market cap or net worth of KRW 19.80 trillion. The enterprise value is 19.48 trillion.
| Market Cap | 19.80T |
| Enterprise Value | 19.48T |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
ALTEOGEN has 53.51 million shares outstanding. The number of shares has increased by 0.82% in one year.
| Current Share Class | 53.51M |
| Shares Outstanding | 53.51M |
| Shares Change (YoY) | +0.82% |
| Shares Change (QoQ) | -0.52% |
| Owned by Insiders (%) | 25.40% |
| Owned by Institutions (%) | 9.97% |
| Float | 39.86M |
Valuation Ratios
The trailing PE ratio is 142.79 and the forward PE ratio is 68.11.
| PE Ratio | 142.79 |
| Forward PE | 68.11 |
| PS Ratio | 91.72 |
| PB Ratio | 36.12 |
| P/TBV Ratio | 44.77 |
| P/FCF Ratio | 195.79 |
| P/OCF Ratio | 159.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 173.36, with an EV/FCF ratio of 192.63.
| EV / Earnings | 137.50 |
| EV / Sales | 90.24 |
| EV / EBITDA | 173.36 |
| EV / EBIT | 182.26 |
| EV / FCF | 192.63 |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.29 |
| Quick Ratio | 3.02 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.07 |
| Interest Coverage | 9.75 |
Financial Efficiency
Return on equity (ROE) is 31.83% and return on invested capital (ROIC) is 75.61%.
| Return on Equity (ROE) | 31.83% |
| Return on Assets (ROA) | 12.06% |
| Return on Invested Capital (ROIC) | 75.61% |
| Return on Capital Employed (ROCE) | 19.34% |
| Weighted Average Cost of Capital (WACC) | 10.17% |
| Revenue Per Employee | 1.36B |
| Profits Per Employee | 890.98M |
| Employee Count | 159 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 13.43 |
Taxes
In the past 12 months, ALTEOGEN has paid 17.56 billion in taxes.
| Income Tax | 17.56B |
| Effective Tax Rate | 10.79% |
Stock Price Statistics
The stock price has increased by +4.03% in the last 52 weeks. The beta is 1.07, so ALTEOGEN's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +4.03% |
| 50-Day Moving Average | 377,050.00 |
| 200-Day Moving Average | 439,847.50 |
| Relative Strength Index (RSI) | 48.23 |
| Average Volume (20 Days) | 318,672 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ALTEOGEN had revenue of KRW 215.86 billion and earned 141.67 billion in profits. Earnings per share was 2,591.24.
| Revenue | 215.86B |
| Gross Profit | 165.60B |
| Operating Income | 106.90B |
| Pretax Income | 162.74B |
| Net Income | 141.67B |
| EBITDA | 112.39B |
| EBIT | 106.90B |
| Earnings Per Share (EPS) | 2,591.24 |
Balance Sheet
The company has 430.02 billion in cash and 7.06 billion in debt, with a net cash position of 422.96 billion or 7,904.35 per share.
| Cash & Cash Equivalents | 430.02B |
| Total Debt | 7.06B |
| Net Cash | 422.96B |
| Net Cash Per Share | 7,904.35 |
| Equity (Book Value) | 548.18B |
| Book Value Per Share | 8,324.17 |
| Working Capital | 334.85B |
Cash Flow
In the last 12 months, operating cash flow was 124.13 billion and capital expenditures -23.01 billion, giving a free cash flow of 101.12 billion.
| Operating Cash Flow | 124.13B |
| Capital Expenditures | -23.01B |
| Depreciation & Amortization | 5.49B |
| Net Borrowing | -5.41B |
| Free Cash Flow | 101.12B |
| FCF Per Share | 1,889.75 |
Margins
Gross margin is 76.72%, with operating and profit margins of 49.52% and 65.63%.
| Gross Margin | 76.72% |
| Operating Margin | 49.52% |
| Pretax Margin | 75.39% |
| Profit Margin | 65.63% |
| EBITDA Margin | 52.07% |
| EBIT Margin | 49.52% |
| FCF Margin | 46.85% |
Dividends & Yields
This stock pays an annual dividend of 371.00, which amounts to a dividend yield of 0.10%.
| Dividend Per Share | 371.00 |
| Dividend Yield | 0.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.82% |
| Shareholder Yield | -0.72% |
| Earnings Yield | 0.72% |
| FCF Yield | 0.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 25, 2022. It was a forward split with a ratio of 1.2.
| Last Split Date | Oct 25, 2022 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
ALTEOGEN has an Altman Z-Score of 90.53 and a Piotroski F-Score of 6.
| Altman Z-Score | 90.53 |
| Piotroski F-Score | 6 |